Trademark: 77602824
Word
B BEAUFORT
Status Date
Friday, March 3, 2017
Registration Number
3825880
Registration Date
Tuesday, July 27, 2010
Filing Date
Wednesday, October 29, 2008
Published for Opposition
Tuesday, July 14, 2009
Cancellation Date
Friday, March 3, 2017
35 Regulatory submission management, namely, assisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management
40 Consulting services in the field of manufacturing compliance and validation, namely, providing technical advice related to the manufacture of pharmaceuticals
42 Contract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies, clinical trial project management and quality assurance, medical writing of investigational drug protocols, and medical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trials, drug development, manufacturing environmental compliance and validation, advanced technology in the pharmaceutical field, and medical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, devices and biologics
45 Legal research, namely, regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others, namely, reviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices; providing information relating to legal affairs, namely, providing regulatory information relating to the development and validation of drugs, devices and biologics; regulatory compliance consulting as it applies to clinical trials, namely, monitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation services, namely, preparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validation, namely, regulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvement, namely, providing independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
Color is not claimed as a feature of the mark.
The mark consists of the letter "B" written in a circle with the word "Beaufort" written to the right of the circle and an arc appearing beneath the letter "B" and the word "Beaufort".
Mar 3, 2017
Cancelled Sec. 8 (6-Yr)
Jun 20, 2016
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 20, 2016
Teas Change Of Owner Address Received
Jul 27, 2010
Registered-Principal Register
Jun 19, 2010
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 18, 2010
Law Office Registration Review Completed
Jun 18, 2010
Assigned To Lie
Jun 3, 2010
Allowed Principal Register - Sou Accepted
May 19, 2010
Assigned To Examiner
Apr 26, 2010
Statement Of Use Processing Complete
Apr 8, 2010
Use Amendment Filed
Apr 26, 2010
Case Assigned To Intent To Use Paralegal
Apr 8, 2010
Teas Statement Of Use Received
Apr 7, 2010
Automatic Update Of Assignment Of Ownership
Apr 6, 2010
Notice Of Approval Of Extension Request E-Mailed
Apr 2, 2010
Extension 1 Granted
Apr 2, 2010
Extension 1 Filed
Apr 2, 2010
Teas Extension Received
Oct 6, 2009
Noa Mailed - Sou Required From Applicant
Jul 14, 2009
Published For Opposition
Jun 24, 2009
Notice Of Publication
Jun 8, 2009
Law Office Publication Review Completed
Jun 8, 2009
Assigned To Lie
Jun 5, 2009
Approved For Pub - Principal Register
Jun 2, 2009
Teas/Email Correspondence Entered
Jun 2, 2009
Correspondence Received In Law Office
Jun 2, 2009
Teas Response To Office Action Received
Feb 3, 2009
Notification Of Non-Final Action E-Mailed
Feb 3, 2009
Non-Final Action E-Mailed
Feb 3, 2009
Non-Final Action Written
Jan 27, 2009
Assigned To Examiner
Nov 4, 2008
Notice Of Design Search Code Mailed
Nov 3, 2008
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
